Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-28
2010-11-09
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S151000
Reexamination Certificate
active
07829557
ABSTRACT:
The present invention provides 2-heterosubstituted 3-aryl-4H-benzopyran-4-one compounds for the treatment of cancers, namely breast cancer. This invention further provides a method of synthesis of 2-(alkylthio)isoflavones that can be carried out at ambient conditions. This invention further provides a method of synthesis of the 2-heterosubstituted 3-aryl-4H-benzopyran-4-one from a 2-(alkylthio)isoflavone. The invention further provides methods of using the 2-heterosubstituted 3-aryl-4H-benzopyran-4-one compounds for the treatment of breast cancer in mammals.
REFERENCES:
patent: 4960908 (1990-10-01), Ito et al.
patent: 5420307 (1995-05-01), Hagen et al.
patent: 5948808 (1999-09-01), Safe
patent: 6150395 (2000-11-01), Firestone et al.
patent: 6608089 (2003-08-01), Bombardelli et al.
patent: 6620838 (2003-09-01), McKie et al.
patent: 7105542 (2006-09-01), Brueggemeier et al.
patent: 7618998 (2009-11-01), Tzeng et al.
patent: WO 95/10513 (1995-04-01), None
patent: WO 98/29403 (1998-07-01), None
patent: WO/00/31081 (2006-06-01), None
Jadhav et al. “Synthesis of 2-aryl . . . ” CA 99:522236 (1983).
Saxena et al. “Flavones and coumarins . . . ” CA 126:1217 (1996).
Liu et al. “Nitrogen containing flavonoids . . . ” Biootg. Med. Chem. Lett. v.17, p. 278-281 (2007).
International Search Report from PCT/US03/24520, mailed Jun. 21, 2004.
Examination Report from European Application No. 03749007.5, dated Feb. 26, 2008.
Jadhav, et al., “Synthesis of 2-aryl-3-arylsulfonyl-t-methylchromones as PCA inhibitors”, CA 99:522236, 1983.
Saxena, et al., “Flavones and coumarins as agents for the treatment of atherosclerosis”, CA 126 1217 (1996).
Kim et al., “Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain”, CA 139:117307, 2003.
Grever et al., “The National Cancer Institute: Cancer Drug Discovery and Development Program”, Seminars in Oncology, vol. 19, pp. 622-6-628, 1992.
King et al., “Medicinal chemistry: Principles and practice”, Ch. 14, Bioisosteres, conformational restriction, and pro-drugs—case history: an example of a conformational restriction approach, pp. 206-209, 1994.
Kim et al., “Novel 2-arylthioisoflavones as potential therapeutic agents for hormone-dependent breast cancer”, Nat Am Chemical Society Meeting, Boston, MA, Aug. 18-22, 2002.
Kim et al., “Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain”, Bioorganic & Medicinal Chemistry Letters, 13, pp. 1475-1478, 2003.
Kim et al., “A convenience one-pot synthesis of 2-(alkylthio)isoflavones from deoxybenzoins using a phase transfer catalyst”, Tetrahedron Letters, vol. 43, No. 35, Aug. 26, 2002 pp. 6113-6115 (3), 2002.
International Search Report from PCT/US05/24520, mailed Jun. 21, 2004.
Notice of Allowance from U.S. Appl. No. 10/634,463, mailed Apr. 28, 2006.
Office action from U.S. Appl. No. 10/634,463, mailed Jan. 19, 2006.
Office action from U.S. Appl. No. 10/634,463, mailed Apr. 28, 2005.
Office action from U.S. Appl. No. 10/634,463, mailed Aug. 3, 2004.
Brueggemeier Robert W.
Kim Young-Woo
Calfee Halter & Griswold LLP
Chang Celia
The Ohio State University Research Foundation
LandOfFree
2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-heterosubstituted 3-aryl-4H-1-benzopyran-4-ones as novel... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236864